ARVO 2023: Apellis Pharmaceuticals presented Phase 3 data analyses of pegcetacoplan injection for GA
April 24th 2023Apellis Pharmaceuticals Inc. delivered an oral presentation at the ARVO Annual Meeting in New Orleans announcing their post hoc analyses from the Phase 3 OAKS and DERBY studies evaluating pegcetacoplan injection (Syfovre) for the treatment of geographic atrophy (GA).
Read More
ARVO 2023: Nonclinical data by Adverum Biotechnologies regarding potential treatment of wet AMD
April 24th 2023Adverum Biotechnologies Inc. shared nonclinical data at ARVO 2023 in New Orleans that staggered, bilateral administration of Ixo-vec in NHPs was well tolerated with encouraging therapeutic activity and no signals of increased inflammation.
Read More
Apellis launches new GA Won't Wait campaign with actor Henry Winkler
April 17th 2023New GA Won't Wait campaign partners Apellis Pharmaceuticals Inc. with actor Henry Winkler. The goal of this campaign is to raise awareness and educate older adults and their families about geographic atrophy (GA).
Read More
Jennifer Lim shares research on vitrectomy combined with KPro surgery
April 14th 2023Jennifer Lim, MD, FARVO joined David Hutton, Managing Editor, Ophthalmology Times®, to discuss her presentation on keratoprosthesis combined with vitrectomy surgery given at this year's Vit-Buckle Society meeting.
Read More
Gene variants point to a potential cause of age-related macular degeneration
April 8th 2023According to National Eye Institute researchers, the variants generate malformed proteins that alter the stability of the membrane attack complex, which may drive a chronic inflammatory response in the retina.
Read More
Report: Physician payments should be tied to inflation-based index
March 16th 2023To support congressional action, 135 health organizations – including the American Academy of Ophthalmology – sent a letter to congressional leaders pointing out that a full inflation-based update is the primary solution to the ongoing problem with the Medicare Physician Fee Schedule.
Read More
UF Health researchers’ gene therapy for retina disorder shows promise in early testing
March 14th 2023According to a University of Florida Health, the researchers used gene therapy to both knock down and replace malfunctioning genetic material that affects light-sensing photoreceptors in the retina.
Read More